CRISPR Therapeutics AG (CRSP)
NASDAQ·Healthcare·Biotechnology
$52.15
+2.25%
Mkt Cap $4.68B
Analyst Ratings
Buy
8
Hold
2
Sell
0
Price Target (27 analysts)
$63.00
Range $33.00 – $82.00
Implied Upside
+20.8%
Consensus $63.00 vs current $52.15
NASDAQ·Healthcare·Biotechnology
$52.15
+2.25%
Mkt Cap $4.68B
Buy
8
Hold
2
Sell
0
Price Target (27 analysts)
$63.00
Range $33.00 – $82.00
+20.8%
Consensus $63.00 vs current $52.15